CIPLA LTD.

Erlocip

ERLOCIP contains Drug / Molecule called “ERLOTINIB”. Erlocip belongs to a class of medications called kinase inhibitors. Erlocip (Erlotinib drug) belongs to Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitors. The medication works by interfering with the protein epidermal growth factor to prevent it from activating enzymes.Cancer cells require these to multiply, grow and spread.

Details
Specification

Indication

Erlocip is used for the treatment of advance or metastatic Non-Small Cell Lung cancer.

Note

Precaution

Erlocip is a prescription drug and should be used under proper medical guidance and advice.
Caution should be exercised in patients with history of stomach problem, liver, kidney, or heart disease during pregnancy and breastfeeding.

Updated On Oct 19, 2019 by Admin